Amy Mahery - 01 Feb 2024 Form 3 Insider Report for CNS Pharmaceuticals, Inc. (CNSP)

Role
Director
Signature
/s/ Christopher Downs, Attorney-in-Fact
Issuer symbol
CNSP
Transactions as of
01 Feb 2024
Net transactions value
$0
Form type
3
Filing time
06 Feb 2024, 10:26:33 UTC
Next filing
10 Apr 2024

No securities are beneficially owned.